Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 132.67M P/E - EPS this Y 35.60% Ern Qtrly Grth -
Income -179.82M Forward P/E -1.15 EPS next Y 7.90% 50D Avg Chg 3.00%
Sales - PEG -0.20 EPS past 5Y - 200D Avg Chg -56.00%
Dividend N/A Price/Book N/A EPS next 5Y 5.20% 52W High Chg -91.00%
Recommedations 2.20 Quick Ratio 5.75 Shares Outstanding 225.58M 52W Low Chg 53.00%
Insider Own 2.25% ROA -37.17% Shares Float 190.99M Beta 1.74
Inst Own 93.17% ROE -480.50% Shares Shorted/Prior 10.76M/14.30M Price 1.39
Gross Margin - Profit Margin - Avg. Volume 2,536,038 Target Price 5.72
Oper. Margin - Earnings Date May 7 Volume 1,718,679 Change 0.00%
About Gossamer Bio, Inc.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Gossamer Bio, Inc. News
03/13/24 13 Best Biotech Stocks To Buy Under $20
03/12/24 Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
03/07/24 Should You Buy Gossamer Bio (GOSS) After Golden Cross?
03/05/24 Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
02/27/24 12 Best Medical Stocks to Buy Under $10
01/31/24 7 Micro-Cap Stocks That Could Majorly Surprise Investors
01/08/24 Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12/13/23 Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023
12/05/23 Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
11/29/23 Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
11/17/23 COO & CFO of Gossamer Bio Picks Up 76% More Stock
11/16/23 Institutions profited after Gossamer Bio, Inc.'s (NASDAQ:GOSS) market cap rose US$59m last week but individual investors profited the most
11/09/23 Gossamer Bio Inc (GOSS) Reports Q3 2023 Financial Results and Business Progress
11/09/23 Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
09:08 AM 12 Best Penny Stocks to Buy Under $1
10/03/23 Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs
09/07/23 Gossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023
08/28/23 TENX: Second Quarter Results
08/08/23 Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
07/24/23 Gossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE Results
GOSS Chatroom

User Image Happy_Feet19 Posted - 17 hours ago

$GOSS No catalyst until 4Q25 - P3 Topline data readout. Does anybody know of any other movers to this stock in the next 1 to 6 months?

User Image MonsieurMonsieur Posted - 21 hours ago

$GOSS do you think it'll ever touch 1$ again?

User Image nastento Posted - 2 days ago

$GOSS

User Image Leviparry Posted - 4 days ago

$GOSS When this finally blows up you'll be glad that you held. This stock is highly slept on.

User Image conart Posted - 4 days ago

$GOSS crooks doing the business :)

User Image nastento Posted - 4 days ago

$GOSS 50% haircut in a month hurts. Let's get an update during q1 CC. Give me a bottom so I can buy more

User Image nastento Posted - 4 days ago

$GOSS unless shit data has been leaked, nothing has changed here

User Image Doorkey Posted - 5 days ago

$MRNS $CTXR Who's next.....$GOSS I hope!

User Image chfrssll Posted - 5 days ago

$GOSS eat these cheapies. Thank me later

User Image nastento Posted - 6 days ago

$GOSS yeah Let's listen to this guy

User Image Target_Trader Posted - 6 days ago

$GOSS why are we tanking non stop dilution?

User Image Doorkey Posted - 6 days ago

$GOSS 30% gain soon I hope... it's overdue.

User Image Invest2live Posted - 6 days ago

$GOSS 1+ coming

User Image OPHcrash Posted - 1 week ago

$GOSS 30 days to cover?

User Image Engine444 Posted - 1 week ago

$GOSS heading back toward $1..

User Image Engine444 Posted - 1 week ago

$GOSS added a few more.. Still under 10K but will add all week a few. .83 is a joke guys.

User Image PhilTheGap Posted - 1 week ago

$GOSS overdone. Reversal inbound

User Image Engine444 Posted - 1 week ago

$GOSS rebound imminent.. Took the gift myself.

User Image nastento Posted - 1 week ago

$GOSS sheesh, getting ugly. So oversold and not even valued at their cash position

User Image Engine444 Posted - 1 week ago

$GOSS my mug nay just have to be put in the POST OFFICE.. Sweet entry

User Image Engine444 Posted - 1 week ago

$HCTI little add here this morning... hang for real news and $3+. Added to $GOSS the most oversold puppy in the kennel. Added to $LGHL this morning, huge AI news is due. Buy the base... poopoo on the chase people.. Bidding still in all 3.

User Image Invest2live Posted - 1 week ago

$NGD 176% already; congrats 🎈🎊🎉 Follow for more research based stock alerts; Cheap shares now $BTDR; $GOSS, $ADBE and $ON

User Image Engine444 Posted - 1 week ago

$GOSS the dip is for investors here with a mindset of $1.50 and a few months out... Getting sub .92 fills is stealing.

User Image Engine444 Posted - 1 week ago

$GOSS you are almost a year early... But, be as negative as you want... I buy here and lower.

User Image Engine444 Posted - 1 week ago

$GOSS .92 is stealing..... Call me a thief.

User Image Wisenheimer Posted - 1 week ago

$GOSS reverse split risk

User Image Doorkey Posted - 1 week ago

$GOSS Think I'm in love. Gossamer announces appointment of Skye Drynan.

User Image Doorkey Posted - 1 week ago

$VERU Also watching $GOSS .92-.95 entry

User Image chfrssll Posted - 1 week ago

$GOSS buying More

User Image nastento Posted - 1 week ago

$GOSS enought cash till 1st half of 2026. Be patient, im buying everyday under 1

Analyst Ratings
Piper Sandler Overweight Mar 27, 24
Goldman Sachs Buy Mar 6, 24
Wedbush Outperform Mar 6, 24
HC Wainwright & Co. Buy Mar 6, 24
HC Wainwright & Co. Buy Jan 8, 24
Wedbush Outperform Dec 19, 23
Wedbush Outperform Nov 10, 23
Wedbush Outperform Aug 11, 23
HC Wainwright & Co. Buy Aug 10, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Giraudo Bryan COO/CFO COO/CFO Nov 13 Buy 0.5644 200,000 112,880 380,010 11/14/23
Christian Waage EVP, Tech Ops and Ad.. EVP, Tech Ops and Admin Mar 20 Buy 1.197 18,500 22,144 32,388 03/22/23
Giraudo Bryan COO/CFO COO/CFO Mar 20 Buy 0.9687 50,000 48,435 70,990 03/22/23
Hasnain Faheem President & CEO President & CEO Mar 20 Buy 1.12 878,572 984,001 4,495,897 03/22/23
Carter Laura Chief Scientific Off.. Chief Scientific Officer Mar 16 Sell 1.098 6,029 6,620 76,263 03/20/23
Aranda Richard Chief Medical Office.. Chief Medical Officer Mar 16 Sell 1.098 7,563 8,304 199,388 03/20/23
Peterson Caryn EVP, Regulatory Affa.. EVP, Regulatory Affairs Mar 16 Sell 1.098 7,564 8,305 53,851 03/20/23
Giraudo Bryan COO/CFO COO/CFO Jul 15 Buy 7.21 13,869 99,995 20,990 07/15/22
Hasnain Faheem President & CEO President & CEO Jul 15 Buy 7.21 138,696 999,998 3,617,325 07/15/22
Aranda Richard Chief Medical Office.. Chief Medical Officer Jun 22 Sell 6.88 1,778 12,233 209,897 06/23/22
Carter Laura Chief Scientific Off.. Chief Scientific Officer May 04 Sell 7.20 1,262 9,086 89,042 05/05/22
Christian Waage EVP, Tech Ops and Ad.. EVP, Tech Ops and Admin Mar 23 Sell 8.915 10,722 95,587 579,008 03/24/22
Hasnain Faheem President & CEO President & CEO Mar 23 Sell 8.915 19,035 169,697 143,465 03/24/22
Giraudo Bryan COO/CFO COO/CFO Mar 23 Sell 8.915 10,722 95,587 99,167 03/24/22
Carter Laura Chief Scientific Off.. Chief Scientific Officer Mar 16 Sell 8.278 5,002 41,407 90,304 03/17/22